Trial intelligence / Profile preview

COCOA-PAD II: Cocoa Flavanols for Peripheral Artery Disease

NCT04794530Phase 3Recruiting

Sponsor
Northwestern University
Start
Nov 2021
Primary completion
Dec 2026
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 3 trial of flavanol-rich cocoa powder in peripheral artery disease (PAD), sponsored by Northwestern University. Started Nov 2021; status: recruiting.

02

Drugs

flavanol-rich cocoa powder
03

Conditions

peripheral artery disease (PAD)

Beyond the preview

Go deeper on NCT04794530.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04794530.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call